121
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Idiopathic Hypertrophic Cranial Pachymeningitis with Scleritis and Optic Disc Involvement: a Case Report and Literature Review

, MM, , MD, PhD, , MD, PhD, , MD, PhD, , MM, , MM, , MD, PhD & , MD, PhDORCID Icon show all
Received 27 Sep 2022, Accepted 16 Feb 2023, Published online: 08 Mar 2023

References

  • Karthik SN, Bhanu K, Velayutham S, Jawahar M. Hypertrophic pachymeningitis. Ann Indian Acad Neurol. Jul 2011;14(3):203–204.
  • Yaylali SA, Akcakaya AA, Işik N, et al. Idiopathic hypertrophic cranial pachymeningitis associated with intermediate uveitis. Neuroophthalmology. 2011 Mar 20;35(2):88–91. doi:10.3109/01658107.2011.559683.
  • Mamelak AN, Kelly WM, Davis RL, Rosenblum ML. Idiopathic hypertrophic cranial pachymeningitis. Report of three cases. J Neurosurg. 1993 Aug;79(2):270–276.
  • Kim EH, Kim SH, Jin MC, et al. Immunoglobulin G4-related hypertrophic pachymeningitis involving cerebral parenchyma [J]. J Neurosurg. 2011;115(6):1242–1247. doi:10.3171/2011.7.JNS1166.
  • Wallace ZS, Carruthers MN, Khosroshahi A, et al. IgG4-related disease and hypertrophic pachymeningitis. Medicine (Baltimore). 2013 Jul;92(4):206–216. doi:10.1097/MD.0b013e31829cce35.
  • Tariq R, Ahmed R. Tuberculous hypertrophic pachymeningitis presenting as visual blurring and headaches [J]. J Pak Med Assoc. 2012;62:966–968.
  • Uchida H, Ogawa Y, Tominaga T. Marked effectiveness of low-dose oral methotrexate for steroid-resistant idiopathic hypertrophic pachymeningitis: case report. Clin Neurol Neurosurg. May 2018;168:30–33. doi:10.1016/j.clineuro.2018.02.035.
  • Bi Z, Shang K, Cao J, et al. Hypertrophic pachymeningitis in Chinese patients: presentation, radiological findings, and clinical course[J]. Biomed Res Int. 2020;2020:2926419. doi:10.1155/2020/2926419.
  • Smith JR, Mackensen F, Rosenbaum JT. Therapy insight: scleritis and its relationship to systemic autoimmune disease. Nat Clin Pract Rheumatol. 2007 Apr;3(4):219–226. doi:10.1038/ncprheum0454.
  • Benson WE. Posterior scleritis. Surv Ophthalmol. 1988 Mar-Apr;32(5):297–316. doi:10.1016/0039-6257(88)90093-8.
  • McCluskey PJ, Watson PG, Lightman S, Haybittle J, Restori M, Branley M. Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology. 1999 Dec;106(12):2380–2386. doi:10.1016/S0161-6420(99)90543-2.
  • Agarwal AM, Dutta Majumder P. Tubercular posterior scleritis: a case report and review of literature. Indian J Ophthalmol. 2019 Aug;67(8):1362–1365.
  • Escott SM, Pyatetsky D. Unilateral nodular scleritis secondary to latent syphilis. Clin Med Res. 2015 Jun;13(2):94–95. doi:10.3121/cmr.2015.1279.
  • Kim EC, Foster CS. Immunomodulatory therapy for the treatment of ocular inflammatory disease: evidence-based medicine recommendations for use. Int Ophthalmol Clin. 2006 Spring;46(2):141–164. doi:10.1097/00004397-200604620-00013.
  • Daniel Diaz J, Sobol EK, Gritz DC. Treatment and management of scleral disorders. Surv Ophthalmol. 2016 Nov-Dec;61(6):702–717. doi:10.1016/j.survophthal.2016.06.002.
  • Oray M, Meese H, Foster CS. Diagnosis and management of non-infectious immune-mediated scleritis: current status and future prospects. Expert Rev Clin Immunol. 2016 Aug;12(8):827–837. doi:10.1586/1744666X.2016.1171713.
  • Dong Z, Gan Y, Zheng H, et al. The Short-Term Outcome of Treatment with Corticosteroids and Immunosuppressive Drugs for Non-Infectious Posterior Scleritis [J]. Chin J Optom Ophthalmol Vis Sci. 2019;21(9):682–688.
  • Cao JH, Oray M, Cocho L, Foster CS. Rituximab in the treatment of refractory noninfectious scleritis. Am J Ophthalmol. Apr 2016;164:22–28. doi:10.1016/j.ajo.2015.12.032.
  • Kim JH, Joo YB, Kim J, Min JK. A case of hypertrophic cranial pachymeningitis presenting with scleritis in a patient with undifferentiated connective tissue disease. J Korean Med Sci. 2010 Jun;25(6):966–969. doi:10.3346/jkms.2010.25.6.966.
  • Kim EC, Lee SJ, Hwang HS, Kim J, Kim MS. Bilateral diffuse scleritis as a first manifestation of immunoglobulin G4-related sclerosing pachymeningitis. Can J Ophthalmol. 2013 Apr;48(2):e31–3. doi:10.1016/j.jcjo.2012.11.006.
  • Oka K, Ocho K, Iwamuro M, Otsuka F. Hypertrophic pachymeningitis accompanying scleritis. Intern Med. 2017 Sep 1;56(17):2383–2384. doi:10.2169/internalmedicine.8850-17.
  • Lee JEH, Subramaniam S, Cheah CF, Chan KH, Adil H, Rare Ocular A. Manifestation of idiopathic hypertrophic cranial pachymeningitis. Cureus. 2021 Dec 23;13(12):e20633. doi:10.7759/cureus.20633.
  • Nakajima I, Taniguchi Y, Mizobuchi T, Kishimoto T, Fukushima A, Fukuda K. Optic neuropathy with headache and palpable temporal arteries due to hypertrophic pachymeningitis rather than giant cell arteritis. Ocul Immunol Inflamm. Apr 2021;1:1–4.
  • Nakajima H, Yamane K, Kimura F, Oku H. Optic perineuritis associated with antineutrophil cytoplasmic autoantibody-related hypertrophic pachymeningitis: a case report. Neurol Sci. 2016 Apr;37(4):641–643. doi:10.1007/s10072-015-2454-0.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.